InBios® COVID-19/Flu A&B RespiraDX™ Rapid Test

US FDA 510(k) Cleared • IVD • CLIA-waived • Point-Of-Care

The InBios® COVID-19/Flu A&B RespiraDX™ Rapid Test is a lateral flow immunochromatographic assay intended for the qualitative detection and differentiation of influenza A, and influenza B nucleoprotein antigens and SARS-CoV-2 nucleocapsid antigen directly in anterior nasal swab samples from individuals with signs and symptoms of respiratory tract infection.

See Instructions For Use below for full intended use.

Resources

Catalog No. RCFP-25
Format ICT (cassette)
Quantity/Kit 25
Time to Result 15 minutes
Shelf Life 24 months
Sample Type Nasal swabs
Storage 36-86°F or 2-30°C
  • This field is for validation purposes and should be left unchanged.

For more information, download the instructions for use via the “Downloads” tab.

Related Products